Cardaci, G., Singh, A., Gurney, H., Zhang, A. Y., Wong, J. Y., Dorff, T. B., Srinivas, S. M., Macaraeg, A., Song, H., Srinivas, S., Ürün, Y., Kucuk, O., Dreicer, R., Barata, P. C., Sartor, A. O., Ngai, S., Robert, A., Ferreira, D. V., Barton, D., Hansen, A. R. (2026). ProTACT: A first-in-human, phase 1 dose escalation and expansion study evaluating the safety, tolerability, and anti-tumor activity of [
                    <sup>225</sup>
                    Ac]Ac-FL-020, an anti-PSMA radioconjugate in patients with mCRPC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps282